Check the Need-Prevalence and Outcome after Transvenous Cardiac Implantable Electric Device Extraction without Reimplantation.
CRT
ICD
extraction
pacing
reimplantation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
07 Sep 2021
07 Sep 2021
Historique:
received:
05
08
2021
revised:
29
08
2021
accepted:
01
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
after transvenous lead extraction (TLE) of cardiac implantable electric devices (CIEDs), some patients may not benefit from device reimplantation. This study sought to analyse predictors and long-term outcome of patients after TLE with vs. without reimplantation in a high-volume centre. all patients undergoing TLE at our centre between January 2010 and November 2015 were included into this analysis. a total of 223 patients (median age 70 years, 22.0% female) were included into the study. Cardiac resynchronization therapy-defibrillator (CRT-D) was the most common device (40.4%) followed by pacemaker (PM) (31.4%), implantable cardioverter-defibrillator (ICD) (26.9%), and cardiac resynchronization therapy-PM (CRT-P) (1.4%). TLE was performed due to infection (55.6%), malfunction (35.9%), system upgrade (6.7%) or other causes (1.8%). In 14.8%, no reimplantation was performed after TLE. At a median follow-up of 41 months, no preventable arrhythmia-related events were documented in the no-reimplantation group, but 11.8% received a new CIED after 17-84 months. While there was no difference in short-term survival, five-year survival was significantly lower in the no-reimplantation group (78.3% vs. 94.7%, in patients undergoing TLE, a re-evaluation of the indication for reimplantation is safe and effective. Reimplantation was not related to preventable arrhythmia events, but all-cause survival was lower.
Sections du résumé
BACKGROUND
BACKGROUND
after transvenous lead extraction (TLE) of cardiac implantable electric devices (CIEDs), some patients may not benefit from device reimplantation. This study sought to analyse predictors and long-term outcome of patients after TLE with vs. without reimplantation in a high-volume centre.
METHODS
METHODS
all patients undergoing TLE at our centre between January 2010 and November 2015 were included into this analysis.
RESULTS
RESULTS
a total of 223 patients (median age 70 years, 22.0% female) were included into the study. Cardiac resynchronization therapy-defibrillator (CRT-D) was the most common device (40.4%) followed by pacemaker (PM) (31.4%), implantable cardioverter-defibrillator (ICD) (26.9%), and cardiac resynchronization therapy-PM (CRT-P) (1.4%). TLE was performed due to infection (55.6%), malfunction (35.9%), system upgrade (6.7%) or other causes (1.8%). In 14.8%, no reimplantation was performed after TLE. At a median follow-up of 41 months, no preventable arrhythmia-related events were documented in the no-reimplantation group, but 11.8% received a new CIED after 17-84 months. While there was no difference in short-term survival, five-year survival was significantly lower in the no-reimplantation group (78.3% vs. 94.7%,
CONCLUSIONS
CONCLUSIONS
in patients undergoing TLE, a re-evaluation of the indication for reimplantation is safe and effective. Reimplantation was not related to preventable arrhythmia events, but all-cause survival was lower.
Identifiants
pubmed: 34575152
pii: jcm10184043
doi: 10.3390/jcm10184043
pmc: PMC8467543
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Circ Arrhythm Electrophysiol. 2017 Mar;10(3):
pubmed: 28292753
J Cardiovasc Electrophysiol. 2016 Sep;27(9):1067-71
pubmed: 27296508
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Eur Heart J. 2013 Aug;34(29):2281-329
pubmed: 23801822
Europace. 2020 Apr 1;22(4):613-621
pubmed: 32087025
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
J Am Coll Cardiol. 2011 Aug 30;58(10):1001-6
pubmed: 21867833
J Innov Card Rhythm Manag. 2019 Dec 15;10(12):3930-3936
pubmed: 32477715
Europace. 2017 Sep 1;19(9):1527-1534
pubmed: 27707785
Heart Rhythm. 2017 Dec;14(12):e503-e551
pubmed: 28919379
Int J Cardiol. 2020 Jun 15;309:84-91
pubmed: 31973885
Int J Nurs Pract. 2002 Jun;8(3):152-7
pubmed: 12000634